eli lilly glp 1 drug Oral GLP-1 Orforglipron Is Approved for Obesity Lilly to Boost Obesity Drug

We identified a subset of metabolites that distinctly characterize epilepsy-associated metabolic changes, including citric acid, glutamic acid, proline, 3-methyl-2-oxovaleric acid and glucose (Fig

What to Look for in Quality Supplements Not all supplements are created equal

They support growth hormone release and protein synthesis, which protects lean tissue during calorie deficits

On March 5, Novo Nordisk released the top-line results from this pivotal kidney outcomes trial: Use of semaglutide in patients with diabetic kidney disease reduced the primary outcomea composite of kidney failure, 50% decline in estimated glomerular filtration rate (eGFR), and cardiovascular (CV) or kidney deathby an impressive 24% (Figure 1)

Results Driven